Paul Russo

Royal Adelaide Hospital — Australia

Medicine · Health Sciences

101h-index48.5kcitations913works2.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Renal cell carcinoma treatment(658), Renal and related cancers(405), Bladder and Urothelial Cancer Treatments(194), Cancer Genomics and Diagnostics(141), Multiple and Secondary Primary Cancers(78)

Publications913 total

34Hypoxia and immune suppression shapes therapeutic outcomes and metastases in clear cell renal cell carcinoma
The Oncologist·2025Open Access
Radiomic biomarkers associated with immune checkpoint blockade response for advanced renal cell carcinoma
Urologic Oncology Seminars and Original Investigations·2025
POS0549 Use of JAK inhibitors in medium- and small-sized vasculitides: a retrospective multicenter study
Annals of the Rheumatic Diseases·2025· 1 citedOpen Access
A CHALLENGING CASE OF SEVERE MITRAL REGURGITATION TREATED WITH MITRAL VALVE REPLACEMENT IN PATIENT WITH REPAIRED TETRALOGY OF FALLOT
European Heart Journal Supplements·2025
An International Delphi Consensus About Tumor Rupture During Robotic Partial Nephrectomy (Researching UnPredictable TUmor RupturE during Robotic Partial Nephrectomy—The RUPTURE Project)
European Urology Open Science·2025· 3 citedOpen Access
MP14-09 THE NATURAL HISTORY OF METASTATIC CLEAR-CELL RENAL CELL CARCINOMA MANAGED WITH LOCAL THERAPY ALONE: SHOULD EVERYONE BE RECEIVING ADJUVANT IMMUNOTHERAPY?
The Journal of Urology·2025
MP28-05 MLH1 MISMATCH REPAIR PREDICTS EXCEPTIONAL RESPONDER PHENOTYPES IN CLEAR-CELL RENAL CELL CARCINOMA
The Journal of Urology·2025
MP28-11 GENOMIC PATTERNS OF METASTATIC EVOLUTION UNDERLYING CLINICAL COURSE OF METASTATIC CLEAR CELL RENAL CELL CARCINOMA
The Journal of Urology·2025
Tumors in Solitary Kidneys Are Not All Equal: Outcomes of Partial Nephrectomy in High-Risk Cases
Urology Practice·2025· 4 cited
CIRCULATING LEPTIN AND IMMUNE-RELATED TRANSCRIPTOMIC SIGNATURES IN TUMOR AND PERINEPHRIC OF CLEAR CELL RENAL CELL CARCINOMA PATIENTS
Urologic Oncology Seminars and Original Investigations·2025
CLINICAL AND GENOMIC CHARACTERIZATION OF A SINGLE-CENTER COHORT OF RENAL CELL CARCINOMA PATIENTS WITH KRAS MUTATION
Urologic Oncology Seminars and Original Investigations·2025
Higher Risk Renal Angiomyolipomas: Surveillance Remains a Safe Management Option
Urology Practice·2025Open Access
Association between clonal hematopoiesis and survival after nephrectomy in patients with renal cell carcinoma.
Journal of Clinical Oncology·2025
Body Composition May Be a Novel Presurgical Risk Factor for Acute Kidney Injury among Clear Cell Renal Cell Cancer Patients Undergoing Radical Nephrectomy.
PubMed·2025Open Access
Gene expression of prostate-specific membrane antigen (FOLH1) in clear cell renal cell carcinoma predicts angiogenesis and response to tyrosine kinase inhibitors
Urologic Oncology Seminars and Original Investigations·2024· 6 citedOpen Access
Supplementary Table S1 from Radiodensities of Skeletal Muscle and Visceral Adipose Tissues Are Prognostic Factors in Clear-Cell Renal Cell Carcinoma
2024Open Access
Data from Radiodensities of Skeletal Muscle and Visceral Adipose Tissues Are Prognostic Factors in Clear-Cell Renal Cell Carcinoma
2024Open Access
Supplementary Table S2 from Radiodensities of Skeletal Muscle and Visceral Adipose Tissues Are Prognostic Factors in Clear-Cell Renal Cell Carcinoma
2024Open Access
Supplementary Table S3 from Radiodensities of Skeletal Muscle and Visceral Adipose Tissues Are Prognostic Factors in Clear-Cell Renal Cell Carcinoma
2024Open Access
Adjuvant Nivolumab for Localized Renal Cell Carcinoma at High Risk of Recurrence After Nephrectomy: Part B of the Randomized, Placebo-Controlled, Phase III CheckMate 914 Trial
Journal of Clinical Oncology·2024· 21 citedOpen Access
page 1 of 46Next →

Frequent Co-authors

Robert J. Motzer(16), Victor E. Reuter(15), A. Ari Hakimi(10), Martin H. Voss(8), Mark E. Snyder(7), Ying‐Bei Chen(6), James J. Hsieh(6), R. Houston Thompson(6), Robert G. Uzzo(5), Jonathan Coleman(5), Satish K. Tickoo(5), Harry W. Herr(5), William C. Huang(4), Madhu Mazumdar(4), Emily H. Cheng(4), Chris Sander(4), Mithat Gönen(4), Guido Dalbagni(4), Bernard H. Bochner(3), Dean F. Bajorin(3)